Serum Calcium And Phosphateleveelsin Patients With Chronic Myeloid Leukemia Taking Different Dose of Tyrosine Kinase Inhibitors

• Autors principals: Bassam Francis Matti (Autor), Shahla'a Fadhil Sabir (Autor), Maysaa Ali Abdul Khaleq (Autor), Marwah Hasan Al kaabi (Autor)
• Format: Llibre
• Publicat: College of Pharmacy / Mustansiriyah University, 2018-03-01T00:00:00Z.
• Matèries: article
• Accés en línia: Connect to this object online.

Objective: chronic myeloid leukemia (CML) is a myeloproliferative confusion characterized by the occurrence of an acquired mutation which affect the hematopoietic stem cell, treatment of CML with tyrosine kinase inhibitors (TKI) has resulted in high response rates compared to the interferon alpha an...